Companion Animal Drugs Market

1. Executive Summary
1.1. Global Market Snapshot
1.2. Key Success Factors
1.3. Strategic Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definitions
3. Research Methodology
3.1. Preliminary Investigation & Research Design
3.2. Secondary Research & Primary Research
3.3. Data Analysis & Econometric Modelling
3.4. Expert Data Validation
4. Key Emerging Trends Analysis
4.1. Supply-Side Trends
4.2. Demand-Side Trends
5. Global Companion Animal Drugs Market Value (US$ Mn) and Volume Analysis
5.1. Global Market Value (US$ Mn) Analysis, 2018 – 2033
5.2. Incremental $ Opportunity Index, 2023-2033
5.3. Global Market Volume Analysis, 2018 – 2033
6. Global Companion Animal Drugs Market Pricing Analysis
6.1. Regional Level Pricing Analysis and Forecast
6.1.1. Manufacturers Level Pricing
6.1.2. Distributor Level Pricing
6.2. Global Pricing Analysis Benchmark
6.3. Cost Breakdown Analysis
7. Cross-Sectional Analysis
7.1. Cross Analysis of Animal TypeW.R.T. Product Type
8. Supply Vs. Demand Analysis
8.1. Regional Supply Vs. Demand Gap Assessment
8.2. Top Producing Countries Analysis
9. Market Background
9.1. Macroeconomic Factors
9.2. Forecast Factors
9.3. Market Dynamics
9.3.1. Driver
9.3.2. Restraint
9.3.3. Opportunity
9.4. Supply Chain Analysis
9.4.1. List Raw Material Suppliers
9.4.2. List of Manufacturers
9.4.3. List of Distributors
9.4.4. List of End-Users
9.4.5. End-Users Consumption Analysis
9.4.6. Average Profitability Margin Analysis
9.5. Covid-19 Impact Assessment
9.5.1. Economy/Cluster Projections
9.5.2. Covid-19 Economic Assessment
9.5.3. Impact on Target Market
9.5.4. Recovery Scenario
9.6. Regulatory Framework
9.6.1. Regulations of Key Countries
9.6.2. Potential Impact of Regulations
9.7. Porter’s Five Forces Analysis
9.8. Technology Landscape
10. Global Companion Animal Drugs Market 2018 – 2033 By Product Type
10.1. Introduction
10.2. Key Market Trends
10.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Product Type [Value (US$ Mn) and Volume Analysis]
10.3.1. Antibiotics
10.3.2. Anti-inflammatory Drugs
10.3.3. Parasiticides
10.3.4. Anti-infectives
10.3.5. Analgesics and Pain Relievers
10.3.6. Behavioral Drugs
10.3.7. Others
10.4. Market Attractiveness Analysis by Product Type
11. Global Companion Animal Drugs Market 2018 – 2033 by Animal Type
11.1. Introduction
11.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Animal Type[Value (US$ Mn) and Volume Analysis]
11.2.1. Dogs
11.2.2. Cats
11.2.3. Horses
11.2.4. Others
11.3. Market Attractiveness Analysis by Animal Type
12. Global Companion Animal Drugs Market 2018 – 2033 by Route of Administration
12.1. Introduction
12.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Route of Administration [Value (US$ Mn) and Volume Analysis]
12.2.1. Oral
12.2.2. Topical
12.2.3. Injectable
12.2.4. Otic
12.2.5. Ophthalmic
12.2.6. Nasal
12.2.7. Others
12.3. Market Attractiveness Analysis by Route of Administration
13. Global Companion Animal Drugs Market 2018 – 2033 by Distribution Channel
13.1. Introduction
13.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Distribution Channel [Value (US$ Mn) and Volume Analysis]
13.2.1. Veterinary Hospitals
13.2.2. Retail Pharmacies
13.2.3. Online Pharmacies Aftermarket
13.3. Market Attractiveness Analysis by Distribution Channel
14. Global Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2018 – 2033 by Region
14.1. Introduction
14.2. Key Market Trends
14.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Region [Value (US$ Mn) and Volume Analysis]
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia-Pacific
14.3.5. Middle East
14.3.6. Africa
14.4. Market Attractiveness Analysis by Region
15. North America Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2022-2033
15.1. Introduction
15.2. Key Market Trends
15.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Product Type
15.3.3. By Animal Type
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Animal Type
15.4.4. By Route of Administration
15.4.5. By Distribution Channel
16. Latin America Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2018 – 2033
16.1. Introduction
16.2. Key Market Trends
16.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Rest of Latin America
16.3.2. By Product Type
16.3.3. By Animal Type
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Animal Type
16.4.4. By Route of Administration
16.4.5. By Distribution Channel
17. Europe Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2018 – 2033
17.1. Introduction
17.2. Key Market Trends
17.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. UK
17.3.1.5. Spain
17.3.1.6. Netherlands
17.3.1.7. Norway
17.3.1.8. Russia
17.3.1.9. Rest of Europe
17.3.2. By Product Type
17.3.3. By Animal Type
17.3.4. By Route of Administration
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Animal Type
17.4.4. By Route of Administration
17.4.5. By Distribution Channel
18. Asia-Pacific Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2018 – 2033
18.1. Introduction
18.2. Key Market Trends
18.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. India
18.3.1.5. Indonesia
18.3.1.6. Thailand
18.3.1.7. Vietnam
18.3.1.8. Australia & New Zealand
18.3.1.9. Rest of Asia-Pacific
18.3.2. By Product Type
18.3.3. By Animal Type
18.3.4. By Route of Administration
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Animal Type
18.4.4. By Route of Administration
18.4.5. By Distribution Channel
19. Middle East Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2018 – 2033
19.1. Introduction
19.2. Key Market Trends
19.3. Pricing Analysis
19.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]
19.4.1. By Country
19.4.1.1. Saudi Arabia
19.4.1.2. Turkey
19.4.1.3. U.A.E.
19.4.1.4. Rest of the Middle East
19.4.2. By Product Type
19.4.3. By Animal Type
19.4.4. By Route of Administration
19.4.5. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product Type
19.5.3. By Animal Type
19.5.4. By Route of Administration
19.5.5. By Distribution Channel
20. Africa Companion Animal Drugs Market Historical Analysis 2017 – 2021 and Forecast 2018 – 2033
20.1. Introduction
20.2. Key Market Trends
20.3. Pricing Analysis
20.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]
20.4.1. By Country
20.4.1.1. South Africa
20.4.1.2. Nigeria
20.4.1.3. Egypt
20.4.1.4. Rest of Africa
20.4.2. By Product Type
20.4.3. By Animal Type
20.4.4. By Route of Administration
20.4.5. By Distribution Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product Type
20.5.3. By Animal Type
20.5.4. By Route of Administration
20.5.5. By Distribution Channel
21. Competition Analysis
21.1. Tier Structure Breakdown
21.2. Market Share Analysis
21.3. Production Capacity Analysis
21.4. Company Footprint Analysis
21.4.1. Product Footprint of Players
21.4.2. Regional Footprint of Players
21.4.3. Channel Footprint of Players
21.5. Brand Preference Analysis
21.6. Competition Dashboard
22. Company Profiles
22.1. Zoetis Inc..
22.1.1. Company Overview
22.1.2. Product & Financial Portfolio
22.1.3. Manufacturing Facilities
22.1.4. Recent Developments
22.1.5. SWOT Analysis
22.1.6. Strategy Overview
22.2. Merck & Co., Inc.
22.3. Eli Lilly and Company
22.4. Boehringer Ingelheim International GmbH
22.5. Bayer AG
22.6. Virbac
22.7. Dechra Pharmaceuticals PLC
22.8. Vetoquinol S.A.
22.9. Ceva Santé Animale
22.10. Idexx Laboratories, Inc.
22.11. Elanco Animal Health
22.12. Archer Daniels Midland Company
22.13. Kindred Biosciences, Inc.
22.14. Phibro Animal Health Corporation
22.15. Chanelle Pharma Group
22.16. MediLab
22.17. Abaxis, Inc.
22.18. VetPharm, Inc.
22.19. Neogen Corporation
22.20. Perrigo Company plc
22.21. others
23. Assumptions and Acronyms